Ionis Pharmaceuticals, Inc. (LON:0JDI)
28.98
-0.09 (-0.30%)
At close: Apr 25, 2025
Ionis Pharmaceuticals Employees
Ionis Pharmaceuticals had 1,069 employees as of December 31, 2024. The number of employees increased by 142 or 15.32% compared to the previous year.
Employees
1,069
Change (1Y)
142
Growth (1Y)
15.32%
Revenue / Employee
526.89K GBP
Profits / Employee
-339.16K GBP
Market Cap
3.55B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Oxford Nanopore Technologies | 1,315 |
Ionis Pharmaceuticals News
- 19 days ago - This Reddit Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
- 23 days ago - Ionis to host expert panel discussion on sHTG - Business Wire
- 26 days ago - Ionis to present at upcoming investor conferences - Business Wire
- 4 weeks ago - Ionis expands partnership with Sobi to include olezarsen commercialization outside the U.S. - Business Wire
- 6 weeks ago - Ionis Pharmaceuticals Partners With Japan-Based Ono Pharmaceutical For Rare Blood Disease Drug In Over $800 Million Deal - Benzinga
- 6 weeks ago - Ionis out licenses blood disorder therapy to Ono in a deal worth up to $940M - Seeking Alpha
- 6 weeks ago - Ono Enters into License Agreement with Ionis Pharmaceuticals for Sapablursen for the Treatment of Polycythemia Vera - Business Wire
- 6 weeks ago - Ionis and Ono announce global license agreement for sapablursen in polycythemia vera - Business Wire